As Jon Pilcher stated recently, Daybue has exceeded expectations and is viewed as an incredibly successful Orphan Drug launch.
If some investors in Neuren think the Daybue sales are disappointing they're clearly just ignorant of the space they're investing in.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.31%
!
$17.78

Share Price, page-13397
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.78 |
Change
0.230(1.31%) |
Mkt cap ! $2.240B |
Open | High | Low | Value | Volume |
$17.83 | $17.99 | $17.35 | $16.12M | 911.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11000 | $17.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.80 | 10070 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11000 | 17.400 |
2 | 2732 | 17.300 |
1 | 300 | 17.100 |
1 | 58 | 17.060 |
1 | 10 | 17.040 |
Price($) | Vol. | No. |
---|---|---|
17.800 | 70 | 1 |
17.940 | 566 | 1 |
17.990 | 73 | 1 |
18.000 | 4313 | 4 |
18.100 | 611 | 2 |
Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
NEU (ASX) Chart |